Cargando…
Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)
BACKGROUND: In clinical trials that recruited patients with early Parkinson’s disease (PD), 4–15% of the participants with a clinical diagnosis of PD had normal dopamine transporter single photon emission computed tomography (DAT SPECT) scans, also called “scans without evidence of dopaminergic defi...
Autores principales: | Suwijn, Sven R., Samim, Hamdia, Eggers, Carsten, Espay, Alberto J., Fox, Susan, Lang, Anthony E., Samuel, Mike, Silverdale, Monty, Verschuur, Constant V.M., Dijk, Joke M., Verberne, Hein J., Booij, Jan, de Bie, Rob M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683040/ https://www.ncbi.nlm.nih.gov/pubmed/32597819 http://dx.doi.org/10.3233/JPD-202090 |
Ejemplares similares
-
Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
por: Nabizadeh, Fardin, et al.
Publicado: (2023) -
SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias
por: Suwijn, Sven R, et al.
Publicado: (2013) -
Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
por: Suwijn, Sven R., et al.
Publicado: (2019) -
Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021) -
Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patients
por: Kim, Mansu, et al.
Publicado: (2016)